<p>This is indicated in the regular treatment of asthma where use of a combination product (long-acting &beta;2-agonist and inhaled corticosteroid) is appropriate:</p>

<ul>
	<li>patients not adequately controlled with inhaled corticosteroids and &#39;as needed&#39; inhaled short acting &beta;2-agonist or</li>
	<li>patients already adequately controlled on both inhaled corticosteroid and long-acting &beta;2-agonist.</li>
</ul>